ESC Premium Access

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study

Congress Presentation

About the speaker

Doctor Xiaoyan Li

Bristol Myers-Squibb, Princeton, NJ (United States of America)
0 follower

10 more presentations in this session

Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population

Speaker: Assistant Professor H. Yu (Seoul, KR)


Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)


Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

Speaker: Mr S. van der Wall (Haarlem, NL)


The new warfarin dosing algorithm for patients with atrial fibrillation and severe chronic kidney disease

Speaker: Doctor Z. Salpagarova (Moscow, RU)


Serum light-chain neurofilament, a brain lesion marker, correlates with CHA2DS2-VASc score among patients with atrial fibrillation: a cross-sectional study

Speaker: Doctor S. Aeschbacher (Basel, CH)


Access the full session

Poster Session 3 - Atrial fibrillation - Stroke prevention

Speakers: Doctor X. Li, Assistant Professor H. Yu, Doctor M. Esteve Pastor, Mr S. van der Wall, Doctor Z. Salpagarova...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb